Literature DB >> 9349155

Syringomatous carcinoma of the eyelid and orbit: a clinical and histopathological challenge.

V P Hoppenreijs1, T T Reuser, C M Mooy, R J de Keizer, M P Mourits.   

Abstract

AIMS: To present three patients with a syringomatous carcinoma (SC). SC is a rare cutaneous neoplasm, most frequently situated on the face and scalp and histologically characterised by an infiltrative pattern of basaloid or squamous cells, a desmoplastic stromal reaction, keratin filled cysts, and granular structures.
METHODS: The clinical histories of the patients with a SC were investigated retrospectively.
RESULTS: Patient 1 had a benign appearing tumour of the lower eyelid. Five tumour excisions were necessary to remove the SC completely. Patient 2 had a tumour on the lateral part of the lower eyelid and in the medial canthal area. The histopathological findings revealed a squamous cell carcinoma, later revised as a SC. In spite of two excisions and one microscopically controlled excision, a recurrence occurred. An exenteration orbitae was recommended. Patient 3, known to have a history of multiple malignant skin tumours after kidney transplantation and use of cyclosporin, presented with a firm mass in the eyebrow region and in the nasal area of the orbit. The pathological diagnosis of this adnexal tumour was difficult. An exenteration was recommended.
CONCLUSIONS: SC is a benign appearing but extremely invasive, locally destructive, slowly growing adnexal tumour, derived from eccrine sweat glands. It is often mistaken, both clinically and microscopically, for other benign and malignant entities. The tumour recurrence is high due to extensive perineural invasion, but regional or distant metastases are rare. The local aggressive nature of the tumour and the high recurrence rate may necessitate mutilating procedures. Optimal treatment consists of a complete microscopically controlled surgical excision with clear surgical margins.

Entities:  

Mesh:

Year:  1997        PMID: 9349155      PMCID: PMC1722280          DOI: 10.1136/bjo.81.8.668

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma).

Authors:  P H Cooper
Journal:  Arch Dermatol       Date:  1986-03

2.  Microcystic adnexal carcinoma of the eyebrow and eyelid.

Authors:  J H Hunts; B C Patel; P D Langer; R L Anderson; J W Gerwels
Journal:  Arch Ophthalmol       Date:  1995-10

3.  Carcinoembryonic antigen in benign sweat gland tumors.

Authors:  N S Penneys; M Nadji; A Morales
Journal:  Arch Dermatol       Date:  1982-04

4.  Sweat gland carcinoma with syringomatous features: a light microscopic and ultrastructural study.

Authors:  S Lipper; S C Peiper
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

5.  Microcystic adnexal carcinoma.

Authors:  P H Cooper; S E Mills
Journal:  J Am Acad Dermatol       Date:  1984-05       Impact factor: 11.527

6.  Microcystic adnexal carcinoma: a distinct clinicopathologic entity.

Authors:  D J Goldstein; R J Barr; D J Santa Cruz
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

7.  Carcinoembryonic antigen in sweat-gland carcinomas.

Authors:  N S Penneys; M Nadji; J Ziegels-Weissman; M Ketabchi; A R Morales
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

8.  Sclerosing sweat duct (syringomatous) carcinoma.

Authors:  P H Cooper; S E Mills; D D Leonard; D J Santa Cruz; J T Headington; R J Barr; D A Katz
Journal:  Am J Surg Pathol       Date:  1985-06       Impact factor: 6.394

9.  Malignant syringoma of the eyelid.

Authors:  H J Glatt; A D Proia; E A Tsoy; B F Fetter; G K Klintworth; R Neuhaus; R L Font
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

10.  Lip reconstruction following resection for an unusual basal-cell carcinoma.

Authors:  D E Kelly; K M Klein; W F Harrigan
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1975-07
View more
  9 in total

1.  Eruptive syringomas in the groin.

Authors:  Ivan V Litvinov; Fatemeh Jafarian
Journal:  CMAJ       Date:  2013-11-18       Impact factor: 8.262

2.  Syringoid eccrine carcinoma of the eyelid presenting as cicatricial entropion.

Authors:  Manjool M Shah; Eric A Steele; Kevin P White; David J Wilson
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Aggressive syringomatous carcinoma of the orbit.

Authors:  Shingo Hasegawa; Eiji Kohmura; Akihiro Ichinose; Shinya Tahara; Atsushi Azumi; Chiho Ohbayashi; Ken-ichi Nibu
Journal:  Skull Base       Date:  2005-11

4.  Unusual presentation of primary orbital microcystic adnexal carcinoma.

Authors:  Wen Ying Wu-Chen; Christina Y Weng; K D A Rajan; Charles Eberhart; Neil R Miller
Journal:  J Neuroophthalmol       Date:  2011-06       Impact factor: 3.042

5.  A case of histiocytoid variant eccrine sweat gland carcinoma of the orbit.

Authors:  Young Min Kim; Jeong Won Kim; Dong-Eun Oh
Journal:  Korean J Ophthalmol       Date:  2011-01-17

6.  A brief review of different types of sweat-gland carcinomas in the eyelid and orbit.

Authors:  Leilei Zhang; Shengfang Ge; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2013-04-09       Impact factor: 4.147

Review 7.  Syringoid Eccrine Carcinoma in the Abdominal Wall: A Rare Case Report and Literature Review.

Authors:  Miguel Augusto Pereira; Luciana Pantaleão; Mayra Rochael
Journal:  Am J Case Rep       Date:  2019-12-19

8.  Rare syringoid eccrine carcinoma of the upper lip and nasal base treated with resection and subsequent innovative reconstruction using an Abbé flap, turbinate flaps and three-stage forehead flap: a case report.

Authors:  Zdeněk Dvořák; Richard Pink; Petr Heinz; Jaroslav Michálek; Petr Krsička
Journal:  World J Surg Oncol       Date:  2022-09-08       Impact factor: 3.253

9.  Syringomatous carcinoma: case report of a rare tumor entity.

Authors:  Basma El khannoussi; Hajar Hechlaf; Issam Lalya; Mohamed Oukabli; Abderrahman Al Bouzidi; Nicolas Ortonne
Journal:  Pan Afr Med J       Date:  2012-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.